CanBas Co (TSE:4575) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4575 CanBas Co Ltd TSE:4575
31 GF Score
Price 円796.00
View Full Analysis

What is CanBas Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4575
31GF Score
CanBas Co Ltd TSE:4575
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CanBas Co Business Description

Address 2-2-1 Otemachi, Numazu, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
31GF Score

Get the complete analysis for TSE:4575

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円796.00
Price